UBS (SWX:UBSG) Stock May Be Undervalued Despite Its 226% Run
UBS Group has delivered a very strong 5 year share price gain, yet current valuation checks still suggest the stock trades at a discount to what its fundamentals might justify. The Excess Returns intrinsic value estimate and market multiple view both lean toward undervaluation, even after this extended run.
- Over the past 5 years, UBS Group has returned about 226%, which puts pressure on any argument that it remains an obvious bargain without further analysis.
- Recent moves such as expanding wealth management in Los Angeles and a larger debt buy back plan can support earnings power, while the ongoing US Senate inquiry into historical Credit Suisse accounts may weigh on perceived risk and reputational strength.
- On a composite view of several valuation checks, UBS Group earns a mixed score of 3 out of 6, which points to a company that looks neither clearly cheap nor clearly expensive on the broader metrics.
For investors, the debate is whether UBS Group's share price already reflects this combination of strong past returns and indications of undervaluation in the Excess Returns model.
Scan beyond UBS Group and compare it with hand picked financial stocks that combine balance sheet strength with valuation support in the solid balance sheet and fundamentals stocks screener (194 results).
Is UBS Group a Bargain on Excess Returns?
The Excess Returns model looks at whether UBS Group is earning more on its equity than investors require, and how long that gap can last. For UBS Group, the inputs are quite punchy. Book value sits at CHF29.12 per share, while stable EPS is modeled at CHF4.59 per share, based on weighted future Return on Equity estimates from 13 analysts.
Those earnings imply an average Return on Equity of 13.77% versus a modeled cost of equity of CHF1.97 per share, leaving an excess return of CHF2.62 per share. Combined with a stable book value estimate of CHF33.32 per share, the Excess Returns framework lands on an intrinsic value of about CHF66.94 per share. Against the current share price, that suggests UBS Group is trading at roughly a 34.3% discount on this method. The ongoing US Senate inquiry into historical Credit Suisse accounts helps explain why the market price may still lag what these economics suggest.
On this Excess Returns view, UBS Group appears undervalued, with the market price sitting well below the model estimate of CHF66.94 per share.
Our Excess Returns analysis suggests UBS Group is undervalued by 34.3%. Track this in your watchlist or portfolio, or discover 181 more high quality undervalued stocks.
Is UBS Group a Bargain on Earnings?
P/E works well for UBS Group because earnings remain a core yardstick for how markets judge large, diversified banks. On this measure, UBS Group trades on a P/E of 17.4x, which is almost identical to the peer average of 17.4x and modestly above the broader capital markets industry at 15.7x. That cluster around peers indicates that investors are valuing the bank broadly in line with comparable institutions on simple headline earnings.
The Fair Ratio for UBS Group sits higher at 24.1x, which is the multiple implied once factors such as profitability profile, scale and risk are incorporated into the model. Compared with the current 17.4x, that is a sizeable gap that suggests the shares are priced below what this framework indicates would be reasonable. Considered alongside the Excess Returns estimate, the P/E check supports the view that the current earnings multiple does not fully reflect the modeled economics.
On the market multiple view, UBS Group appears undervalued, with its current P/E sitting well below the Fair Ratio implied by the company’s fundamentals.
See what the numbers say about this price — find out in our valuation breakdown.
The UBS Group Narrative: What Would Justify Today's Price?
Simply Wall St Narratives for UBS Group pick up where this valuation puzzle leaves off. They spell out which combinations of future growth, profitability and earnings power would need to hold for UBS Group's equity to be worth materially more or materially less than today’s market price. Each narrative connects its number to a clear view on how growth, margins and key risks might evolve, giving you something concrete to revisit whenever new information appears.
Community views on UBS Group pull in opposite directions, with one camp focused on execution upside and the other fixated on regulatory and integration strain.
Bull case: roughly fairly valued
"Integration of Credit Suisse and investment in digital infrastructure are enhancing efficiency, scalability, and profitability, boosting margins and long-term earnings potential…"
Read the full Bull Case to see why UBS Group could be undervalued
Bear case: 29% overvalued
"The proposed overhaul of Swiss bank capital regulation would require UBS to hold at least $24 billion, and potentially up to $42 billion, in additional capital at the parent bank and group level, materially depressing returns on equity and limiting the company's ability to distribute capital to shareholders over the long term…"
Read the full Bear Case to see why UBS Group could be overvalued
Do you think there's more to the story for UBS Group? Head over to our Community to see what others are saying!
The Bottom Line
UBS Group screens as undervalued on both the Excess Returns intrinsic value estimate and the P/E based market multiple, yet the mixed overall score hints that the margin of safety is not unquestioned. The gap between the intrinsic value estimate and current price only matters if the bank can translate its post Credit Suisse scale into durable returns without regulatory or legal shocks eating into that edge. Everything now revolves around one issue: Does the current discount reflect a mispriced opportunity, or is the market correctly building in the risk that capital demands and investigations keep a lid on what shareholders ultimately receive over time?
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com